SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-042010
Filing Date
2020-07-09
Accepted
2020-07-09 18:00:09
Documents
2
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4079
2 POA DOCUMENT poa.txt EX-24.3_928439 2962
  Complete submission text file 0001209191-20-042010.txt   8442
Mailing Address C/O MIRATI THERAPEUTICS INC. 9393 TOWN CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
Gergen Mark J (Reporting) CIK: 0001373110 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39376 | Film No.: 201021272

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)